Meylis Artykov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meylis Artykov has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Hakan Bahadir Haberal
Department of Urology, Ankara Etlik City Hospital, Ministry of Health, University of Health Sciences, Ankara, Turkiye
6 shared publications - Sertac Yazici
Department of Urology, School of Medicine, Hacettepe University, Ankara 06800, Türkiye
4 shared publications - Ahmet Gudeloglu
Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey
3 shared publications - Berk Hazir
Department of Urology, Hacettepe University School of Medicine, Ankara, Turkey
3 shared publications - Cenk Yücel Bilen
Hacettepe Univ, Dept Urol, Fac Med, Ankara, Turkey
3 shared publications Sertac Yazici
Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
3 shared publications
Latest Publications
- Open Access
- 29 June 2025
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 12 (6) , 225-229
The change of curve and clinical effect of hepatic and portal vein flow forms in the pregnancy progress
Objective: Pregnancy involves profound physiological adaptations, including significant hemodynamic changes. This study aimed to evaluate alterations in hepatic and portal vein flow patterns throughout gestation using Doppler ultrasonography and to define reference values that may help avoid misinterpretation and unnecessary interventions. Method: A total of 215 healthy pregnant women between 10 and 40 weeks of gestation, all with singleton pregnancies and no underlying conditions, were included. A control group of 22 healthy, non-pregnant women of reproductive age was also assessed. Doppler measurements were obtained from the middle hepatic vein and central portal vein using subcostal or intercostal approaches. Parameters recorded included hepatic vein waveform morphology, portal vein diameter, velocity, and calculated flow rate. Results: All control subjects exhibited triphasic hepatic vein flow. As gestation progressed, hepatic vein flow patterns in pregnant women shifted significantly from triphasic to biphasic and monophasic waveforms (p < 0.001). In late pregnancy, monophasic flow was observed in 72.6% of subjects, compared to 5.6% in early pregnancy. Portal vein flow velocity was significantly higher in all trimesters compared to the control group (p < 0.001), peaking between 15 and 25 weeks, then declining. Portal vein diameter increased steadily across gestation, showing a strong positive correlation with gestational age (R² = 0.346, p < 0.001). A statistically significant negative correlation was observed between portal vein velocity and gestational week (R² = 0.416, p < 0.001). Portal vein flow rate also rose throughout pregnancy but did not differ significantly between trimesters (p > 0.05). Conclusion: Hepatic and portal vein Doppler flow patterns undergo significant, progressive alterations during pregnancy. Recognizing these physiological changes—and referencing established normal values—is essential to avoid misdiagnosis of pathological conditions and to guide accurate clinical assessment.
- 29 June 2025
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 12 (6) , 225-229
Open AccessThe change of curve and clinical effect of hepatic and portal vein flow forms in the pregnancy progress
Objective: Pregnancy involves profound physiological adaptations, including significant hemodynamic changes. This study aimed to evaluate alterations in hepatic and portal vein flow patterns throughout gestation using Doppler ultrasonography and to define reference values that may help avoid misinterpretation and unnecessary interventions. Method: A total of 215 healthy pregnant women between 10 and 40 weeks of gestation, all with singleton pregnancies and no underlying conditions, were included. A control group of 22 healthy, non-pregnant women of reproductive age was also assessed. Doppler measurements were obtained from the middle hepatic vein and central portal vein using subcostal or intercostal approaches. Parameters recorded included hepatic vein waveform morphology, portal vein diameter, velocity, and calculated flow rate. Results: All control subjects exhibited triphasic hepatic vein flow. As gestation progressed, hepatic vein flow patterns in pregnant women shifted significantly from triphasic to biphasic and monophasic waveforms (p < 0.001). In late pregnancy, monophasic flow was observed in 72.6% of subjects, compared to 5.6% in early pregnancy. Portal vein flow velocity was significantly higher in all trimesters compared to the control group (p < 0.001), peaking between 15 and 25 weeks, then declining. Portal vein diameter increased steadily across gestation, showing a strong positive correlation with gestational age (R² = 0.346, p < 0.001). A statistically significant negative correlation was observed between portal vein velocity and gestational week (R² = 0.416, p < 0.001). Portal vein flow rate also rose throughout pregnancy but did not differ significantly between trimesters (p > 0.05). Conclusion: Hepatic and portal vein Doppler flow patterns undergo significant, progressive alterations during pregnancy. Recognizing these physiological changes—and referencing established normal values—is essential to avoid misdiagnosis of pathological conditions and to guide accurate clinical assessment.
- 25 April 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (7) , 1709-1717
In vitro effects of β3‐adrenoceptor agonist mirabegron on the human ureter
Introduction: This study aimed to investigate the effect of mirabegron, a β3‐adrenoceptor agonist with widespread clinical use for treating overactive bladder disease, on isolated healthy human ureter strips.Materials and Methods: This was a prospective study employing a series of in vitro organ bath experiments using ureteral tissues of kidney grafts from 10 healthy donors. The ureteral strips were subjected to cumulative mirabegron concentrations (10−9–10−4.5 M). Effects on frequency or amplitude of spontaneous, 10 mM KCl‐ or EFS‐induced contractions were evaluated.Results: Mirabegron decreased the frequency of spontaneous ureteric contraction in a concentration‐dependent manner. Statistically significant decrease in the frequency of spontaneous contraction was observed at 10−8–10−4.5 M. In 10 mM KCl medium, statistically significant change in frequency was observed at 10−9–10−4.5 M. Statistically significant decrease in the amplitudes of spontaneous contraction was observed at 10−7–10−4.5 M. In a 10 mM KCl medium, statistically significant change in amplitudes was observed at 10−8–10−4.5 M.Conclusions: Mirabegron reduced the amplitude and frequency of human ureter activity in in vitro organ bath studies. This effect was achieved in a dose‐dependent manner on isolated tissue strips. Although monotherapy with mirabegron remains uncertain, this study has the potential to elucidate the mechanism underlying the effectiveness of mirabegron, particularly in combination therapy for ureteral stones.
- 25 April 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (7) , 1709-1717
In vitro effects of β3‐adrenoceptor agonist mirabegron on the human ureter
Introduction: This study aimed to investigate the effect of mirabegron, a β3‐adrenoceptor agonist with widespread clinical use for treating overactive bladder disease, on isolated healthy human ureter strips.Materials and Methods: This was a prospective study employing a series of in vitro organ bath experiments using ureteral tissues of kidney grafts from 10 healthy donors. The ureteral strips were subjected to cumulative mirabegron concentrations (10−9–10−4.5 M). Effects on frequency or amplitude of spontaneous, 10 mM KCl‐ or EFS‐induced contractions were evaluated.Results: Mirabegron decreased the frequency of spontaneous ureteric contraction in a concentration‐dependent manner. Statistically significant decrease in the frequency of spontaneous contraction was observed at 10−8–10−4.5 M. In 10 mM KCl medium, statistically significant change in frequency was observed at 10−9–10−4.5 M. Statistically significant decrease in the amplitudes of spontaneous contraction was observed at 10−7–10−4.5 M. In a 10 mM KCl medium, statistically significant change in amplitudes was observed at 10−8–10−4.5 M.Conclusions: Mirabegron reduced the amplitude and frequency of human ureter activity in in vitro organ bath studies. This effect was achieved in a dose‐dependent manner on isolated tissue strips. Although monotherapy with mirabegron remains uncertain, this study has the potential to elucidate the mechanism underlying the effectiveness of mirabegron, particularly in combination therapy for ureteral stones.
- 5 June 2023
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 10 (2) , 139-146
Risk Factors for Complications in Simple Nephrectomy: 17-Year Results from Single Institution
- 5 June 2023
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 10 (2) , 139-146
Risk Factors for Complications in Simple Nephrectomy: 17-Year Results from Single Institution
- Open Access
- 1 June 2023
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 11 (3) , qfad042
Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction
Increased carotid artery intima-media thickness (CIMT) has been shown to be associated with erectile dysfunction (ED), but studies evaluating the efficacy of CIMT in predicting drug response are lacking in the literature. We aimed to evaluate the efficacy of CIMT in predicting the response to phosphodiesterase-5 inhibitors (PDE5-I). A total of 274 subjects were divided into two groups: ED patients (n = 150) and controls (n = 124). The patients in the ED group were further divided into the subgroups of severe, moderate, mild–moderate, and mild ED. Blood tests, carotid ultrasonography, and the International Index of Erectile Function-5 (IIEF-5) diagnostic tool were applied to all subjects. Tadalafil was administered to each patient. The patients were re-evaluated using the IIEF-5 questionnaire after 2 months of treatment. According to their response to medication, the patients were evaluated as responders or nonresponders. Increased CIMT was significantly associated with the failure of PDE5-I therapy, especially in patients with moderate/mild-moderate ED. Fasting blood glucose, body mass index, and CIMT were significantly higher in the ED group compared to the control group (P = .021, P = .006, and P < .001, respectively). The IIEF-5 score was significantly lower in the ED group (P < .001). CIMT was significantly correlated with the IIEF-5 score. When the total patient group was evaluated, the CIMT value of the responders was significantly lower than that of the nonresponders (P = .001). CIMT was significantly higher among the nonresponders with moderate/mild-moderate ED compared to the responders (P = .004 and .008, respectively), while there was no significant difference in CIMT between the responders and nonresponders with severe or mild ED. A receiver operating characteristic (ROC) analysis of CIMT was performed for discrimination between nonresponders and responders with moderate/mild-moderate ED. The area under the ROC curve was 0.801 (0.682–0.921) (P = .001), and the cutoff value was determined to be 0.825 mm, at which CIMT predicted the response to treatment with 65% sensitivity and 89% specificity. Using a validated CIMT cutoff value can help the physician inform the patient about the possibility of drug failure and avoid attempting second-line therapy too soon. There are three main limitations to our study. First, the number of participants was low. Second, ultrasound is a relatively subjective method, and third, all measurements were made by the same radiologist. CIMT can be used as a predictor of response to PDE5-I therapies in patients with moderate/mild–moderate ED.
- 1 June 2023
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 11 (3) , qfad042
Open AccessCarotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction
Increased carotid artery intima-media thickness (CIMT) has been shown to be associated with erectile dysfunction (ED), but studies evaluating the efficacy of CIMT in predicting drug response are lacking in the literature. We aimed to evaluate the efficacy of CIMT in predicting the response to phosphodiesterase-5 inhibitors (PDE5-I). A total of 274 subjects were divided into two groups: ED patients (n = 150) and controls (n = 124). The patients in the ED group were further divided into the subgroups of severe, moderate, mild–moderate, and mild ED. Blood tests, carotid ultrasonography, and the International Index of Erectile Function-5 (IIEF-5) diagnostic tool were applied to all subjects. Tadalafil was administered to each patient. The patients were re-evaluated using the IIEF-5 questionnaire after 2 months of treatment. According to their response to medication, the patients were evaluated as responders or nonresponders. Increased CIMT was significantly associated with the failure of PDE5-I therapy, especially in patients with moderate/mild-moderate ED. Fasting blood glucose, body mass index, and CIMT were significantly higher in the ED group compared to the control group (P = .021, P = .006, and P < .001, respectively). The IIEF-5 score was significantly lower in the ED group (P < .001). CIMT was significantly correlated with the IIEF-5 score. When the total patient group was evaluated, the CIMT value of the responders was significantly lower than that of the nonresponders (P = .001). CIMT was significantly higher among the nonresponders with moderate/mild-moderate ED compared to the responders (P = .004 and .008, respectively), while there was no significant difference in CIMT between the responders and nonresponders with severe or mild ED. A receiver operating characteristic (ROC) analysis of CIMT was performed for discrimination between nonresponders and responders with moderate/mild-moderate ED. The area under the ROC curve was 0.801 (0.682–0.921) (P = .001), and the cutoff value was determined to be 0.825 mm, at which CIMT predicted the response to treatment with 65% sensitivity and 89% specificity. Using a validated CIMT cutoff value can help the physician inform the patient about the possibility of drug failure and avoid attempting second-line therapy too soon. There are three main limitations to our study. First, the number of participants was low. Second, ultrasound is a relatively subjective method, and third, all measurements were made by the same radiologist. CIMT can be used as a predictor of response to PDE5-I therapies in patients with moderate/mild–moderate ED.
- Open Access
- 28 June 2022
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 56 (2) , 284-290
Impact of variant histology on clinical and pathological outcomes in patients with upper urinary tract urothelial carcinoma
The Medical Bulletin of Sisli Etfal Hospital
- 28 June 2022
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 56 (2) , 284-290
Open AccessImpact of variant histology on clinical and pathological outcomes in patients with upper urinary tract urothelial carcinoma
The Medical Bulletin of Sisli Etfal Hospital
- Open Access
- 1 May 2022
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 32 (05) , 565-569
Safety of Minimally Invasive Surgical Techniques in Large Adrenal Lesions: A Single-Centre Study
To compare perioperative outcomes of minimally invasive surgery for ≥5 cm and <5 cm adrenal lesions. Retrospective cohort study. Hacettepe University School of Medicine, Ankara, Turkey, between October 2007 and September 2019. Data of 83 patients operated for adrenal lesions was collected retrospectively. Patients were categorized into two groups based on the size of the adrenal gland as <5 cm and ≥5 cm. The groups were compared in terms of perioperative outcomes. The median age of the patients was 51 (41-60) years, with a female-to-male ratio of 27/56. The median follow-up period was 27 (11.5-91) months. Of 83 adrenal masses, 60 (72.3%) were in the <5 cm group and 23 (27.7%) were in the ≥5 cm group. Fifteen (18.1%) patients underwent adrenalectomy for lung cancer metastasis, whereas three (3.6%) for renal cell carcinoma metastasis. The overall rate of post-operative complications was 10.8%. Post-operative complication rates were similar in each group (p=0.433). Operation time was found to be significantly higher in patients with large adrenal masses (p=0.003). Minimally invasive surgical techniques have the same perioperative results in the group with adrenal lesions ≥5 cm compared to <5 cm and may be safely employed in this group of patients. Laparoscopy, Robotic assisted laparoscopy, Adrenalectomy, Metastasectomy, Adrenal gland neoplasms.
- 1 May 2022
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 32 (05) , 565-569
Open AccessSafety of Minimally Invasive Surgical Techniques in Large Adrenal Lesions: A Single-Centre Study
To compare perioperative outcomes of minimally invasive surgery for ≥5 cm and <5 cm adrenal lesions. Retrospective cohort study. Hacettepe University School of Medicine, Ankara, Turkey, between October 2007 and September 2019. Data of 83 patients operated for adrenal lesions was collected retrospectively. Patients were categorized into two groups based on the size of the adrenal gland as <5 cm and ≥5 cm. The groups were compared in terms of perioperative outcomes. The median age of the patients was 51 (41-60) years, with a female-to-male ratio of 27/56. The median follow-up period was 27 (11.5-91) months. Of 83 adrenal masses, 60 (72.3%) were in the <5 cm group and 23 (27.7%) were in the ≥5 cm group. Fifteen (18.1%) patients underwent adrenalectomy for lung cancer metastasis, whereas three (3.6%) for renal cell carcinoma metastasis. The overall rate of post-operative complications was 10.8%. Post-operative complication rates were similar in each group (p=0.433). Operation time was found to be significantly higher in patients with large adrenal masses (p=0.003). Minimally invasive surgical techniques have the same perioperative results in the group with adrenal lesions ≥5 cm compared to <5 cm and may be safely employed in this group of patients. Laparoscopy, Robotic assisted laparoscopy, Adrenalectomy, Metastasectomy, Adrenal gland neoplasms.
- 9 June 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (2) , 118-122
A Technique Which We Should Consider More: Temporary Cutaneous Ureterostomy
- 9 June 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (2) , 118-122
A Technique Which We Should Consider More: Temporary Cutaneous Ureterostomy
- 3 March 2021
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 20 (1) , 67-72
Acute Ischemic Stroke Following Chemotherapy for Malignant Mixed Testicular Germ Cell Tumour: Does Cisplatin Play a Role?
- 3 March 2021
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 20 (1) , 67-72
Acute Ischemic Stroke Following Chemotherapy for Malignant Mixed Testicular Germ Cell Tumour: Does Cisplatin Play a Role?
- Open Access
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 215-217
Primary Leiomyosarcoma of the Prostate Invading the Rectum and Bladder
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 215-217
Open AccessPrimary Leiomyosarcoma of the Prostate Invading the Rectum and Bladder
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 218-219
Robotic Seminal Vesicle Surgery: The Key Steps
- 1 December 2020
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 19 (4) , 218-219
Robotic Seminal Vesicle Surgery: The Key Steps